Full Scan Market Brief
Full Scan Market Brief
Full Scan Market Brief — March 3, 2026
Market Vibe
The music stopped this week. What looked like a market cooling off on Feb 26 turned out to be a head fake of the highest order. VOO shed 19 RSI points in five days — from a comfortable 58 down to 39, breaking below its 20-day moving average. QQQ followed suit, dropping to RSI 43. And that "calming" VIXY reading of RSI 45 last week? It ripped to 65. The fear is real, it is accelerating, and anybody who bought the dip on the Feb 26 "all clear" is now underwater. This is not a dip. This is a breakdown attempt.
The rotation story is striking. Energy (XLE at RSI 79), emerging markets (EEM +6% on the month), industrials, and gold are absorbing the flows. Gold is up 21% in 30 days and its RSI is only 52 — that is not a speculative spike, that is institutional accumulation. When you see VIXY, GLD, and TLT all rising simultaneously, institutions are not hedging a little uncertainty — they are building bunkers. Meanwhile, the Nasdaq is down 3.4% on the month while small caps (IWM) are up 7.1%, a 10-point spread that screams rotation out of growth and into value/domestic. Dividend ETFs like SCHD (RSI 90!) and VYM (RSI 87) are getting bid like they are going out of style — or rather, like everything else is.
The weirdest part? Cybersecurity is getting absolutely destroyed in a world where you would think cybersecurity budgets only go up. BUG is down 15% in a month. CIBR down 11.5%. HACK down 8%. This looks like government budget scrutiny spilling into the private-sector narrative. And ARKK at RSI 24 is in full capitulation territory — the innovation proxy is waving a white flag. The Feb 26 bounce was a trap across the board.
The Wild & Whacky
HIMS at RSI 4. Four. That is not a typo. And insiders are selling $184M worth into it. This is a broken thesis, not a buying opportunity. When insiders flee at RSI 4, the thesis is dead.
ISRG at RSI 9 with $241M in insider selling. A surgical robotics monopoly trading at capitulation levels while its own management dumps shares. That should make you deeply uncomfortable about catching that knife.
PLTR surged +14.3% in 7 days while NVDA dropped 22 RSI points. Same sector, opposite directions. PLTR is trading on a defense/government AI narrative that has completely decoupled from the consumer AI story. Whether that divergence holds or snaps back is the million-dollar question.
AMZN insiders have sold $10.9 BILLION while the stock sits at RSI 25. This is the largest insider dump in the scan by a massive margin. Even if some of this is pre-programmed Bezos selling, the sheer scale at this price level is a flashing amber light.
PYPL pulled off the magic trick: RSI 13 on Feb 22, now RSI 66. A 53-point RSI swing in under two weeks. That is what quality oversold entries DO when they work. The opportunity has now passed.
ESTC collapsed from +2.9% to -10.8% in a single week. One of the most violent reversals in the bench-signals portfolio. No news, just the risk-off tide pulling everything down.
ASAN: the golden signal that failed across all three strategies. Insiders buying $8.3M at RSI 15 — textbook golden signal, 4th consecutive scan. Every strategy bought it. Every strategy got stopped out. Total damage: $4,192. The lesson is painful but important: golden signals cannot fight a macro regime change.
CEG at +19.9% — literally one tick from being the first closed winner in bench-signals. The nuclear power trade is the gift that keeps giving.
XLE at RSI 79 while cybersec ETFs crash. Energy surging on geopolitical fear while the sector you'd think benefits from geopolitical tension (cybersec) gets annihilated. Make it make sense.
Paper Trade Report Card
Claude-Trader: +2.15% (declining)
The only strategy still in the green, but the bloom is off the rose — down from +2.27% last scan. Holding 18 positions with 61% in cash, which is the right posture for this market.
Big move this scan: Sold ASAN at $7.26 for a -26.7% loss ($530 realized), bought AVGO at $313.78 (RSI 29, AI ASIC monopoly). Smart rotation from speculative small-cap to mega-cap quality.
| Position | Status |
|---|---|
| Best: CRSP | +13.1% — gene editing thesis holding strong |
| Best: INTU | +11.1% — post-earnings gap, biggest dollar gainer (+$434) |
| Worst: TMO | -6.7% — only 9.8% above its stop, AND insiders are selling $309M |
| Watch: SNOW | -3.0% — weakened further, 14.2% above stop |
Worry list: TMO is the closest to stop-loss at 9.8% above the trigger. With insiders selling $309M, the conviction to hold is eroding. Six positions have stale data (NFLX, ISRG, ADBE, ORCL, NOW, CRM) — any of these could have already breached stops.
Claude-Momentum: -1.15% (declining)
Slid from -0.60% to -1.15% on the ASAN stop-loss. Three closed trades, three losses, $1,573 in total realized losses. The momentum strategy is learning the hard way that buying oversold bounces in a risk-off market is a rough game.
Big move this scan: Same as trader — sold ASAN (-24.9%, loss of $988), bought AVGO (15 shares at $313.84).
| Position | Status |
|---|---|
| Best: INTU | +10.5% — approaching +20% profit target ($470.80) |
| Best: SNOW | +5.8% — steady performer |
| Worst: ORCL | -2.6% — only 8.2% above its -10% stop. Closest to the exit door. |
YOLO: -1.80% (declining sharply)
This is where the ASAN lesson hurts the most. YOLO went max-size on the golden signal — 1,009 shares at $9.91 — and ate a $2,674 loss when it got stopped out at $7.26. First realized loss for the strategy, and it is a big one.
Big move this scan: Sold ASAN for -26.7% (-$2,674), bought AVGO (32 shares, $10,041). The largest AVGO position across all strategies.
| Position | Status |
|---|---|
| Best: CRSP | +13.1% — the reliable performer |
| Best: WDAY | +3.6% — SaaS laggard thesis working |
| Worst: HIMS | -2.9% with RSI 4 and broken thesis. Still above -20% stop but the writing is on the wall |
| Watch: TQQQ | -1.4% — 3x leverage drag in risk-off. This will bleed. |
Bench-Signals: -1.0% (0 wins / 3 losses)
The broadest strategy with 46 open signals and 3 closed — all losses. Total realized damage: -$600 (WDAY -$200, MDB -$248, HIMS -$152).
This scan: Closed MDB at -24.8% (guidance cut blowup) and HIMS at -15.2% (FDA risk + insider selling). Added three new defensive signals: LOW (RSI 25), HD (RSI 31), and GIS (RSI 30).
| Signal | Status |
|---|---|
| Best: CEG | +19.9% — ONE TICK from the first win at +20%. Nuclear power thesis. |
| Best: CRSP | +13.1% — consistent performer |
| Best: PYPL | +11.0% — the oversold bounce that actually worked |
| Worst: AMD | -11.7% — approaching -15% stop ($183.81) |
| Worst: OKTA | -11.2% — cybersec selloff dragging it toward stop |
| Worst: ESTC | -10.8% — collapsed from +2.9% this week |
The Big Picture
The Feb 26 read was cautiously optimistic — VIXY was cooling, some SaaS names were bouncing, gold was consolidating. All wrong. The market turned sharply risk-off, VOO broke below its moving average, fear spiked to RSI 65, and the only things working are gold, bonds, energy, and dividend ETFs. The regime has shifted from "selective buying into oversold names" to "cash preservation until VIXY drops below 50." The ASAN golden-signal setup failed despite being a top-decile technical read — a reminder that even the best individual setups cannot fight a macro regime shift, especially when stale data masks the damage. Going forward, watch three things: (1) whether VOO holds $610-620 support or breaks into a deeper correction, (2) whether CEG clears its +20% threshold, and (3) the AMD/OKTA/ESTC trio approaching their stops — three simultaneous breakdowns would confirm the risk-off read. The right posture is defensive, cash-heavy, and patient. The bargain bin is getting richer by the day (ORCL at RSI 15, ADBE at RSI 30, AVGO at RSI 29), but the regime says wait.
Sources
Price, RSI and trend figures read from the desk's validated daily scan
summaries (research/market-engine/data/summaries/). No number in this note was
computed in prose.
Related
8 eventsNo direct external sources are attached to this read.